Gene transfer into the peritoneal cavity by nonviral methods may provide an effective therapeutic approach for peritoneal diseases. Herein, we investigated the feasibility and the effectiveness of ultrasound-microbubble-mediated delivery of naked plasmid DNA into the peritoneal cavity in rats. Following the intraperitoneal or the intravenous administration of a mixture of plasmid DNA (100 mg) and ultrasound contrast agent microbubbles, an ultrasound transducer was applied on the abdominal wall. The reporter pTRE plasmid encoding Smad7 was used to evaluate transfection efficiency. Smad7 expression was induced by doxycycline in drinking water. We detected less than 10% apoptotic cells and no inflammatory reaction in peritoneal tissues following the ultrasound-microbubble-mediated transfection. More importantly, the insonation significantly improved the transfection efficiency in peritoneal tissues. The transfection efficiency by intraperitoneal delivery route was higher than the intravenous route. The reporter gene, pTRE-Smad7, was readily detected in the parietal peritoneum, mesentery, greater omentum and adipose tissue. The peak of transgene expression occurred 2 days after transfection and the transgene expression diminished in a time-dependent manner thereafter. Overall, the effectiveness and simplicity of the ultrasound-microbubble-mediated system may provide a promising nonviral means for improving gene delivery for treating peritoneal diseases in vivo.
Introduction
Gene transfer into the peritoneal cavity is an attractive therapeutic approach for protecting the peritoneum from injuries due to long term peritoneal dialysis, peritonitis and intra-abdominal surgery, maintaining the membrane integrity and preserving the overall peritoneal structure and function. 1 Transfection efficiency and safety are most essential considerations for the in vivo gene delivery. Viral vectors have proven to be the most efficient for in vivo gene transfer to a variety of tissues and organs, [2] [3] [4] [5] but immunogenicity, cytotoxicity, tendency of mutanogenesis and low tissue specificity are limiting factors for their practical use. 6 Intraperitoneal gene transfer of viral vectors may evoke inflammatory response and host immune response as reflected by increased level of inflammatory cytokines and local recruitment of neutrophils and lymphocytes. Moreover, neutralizing antibodies to viruses prevent readministration of viral-mediated gene transfection for treating abdominal diseases. 7 Hence, a nonviral gene transfer method that has high transfection efficiency without inducing detrimental side effects is urgently in need for practical use. 8 For nonviral transfection, the naked DNA can be delivered into cells or tissues either by chemical carriers such as liposome and cationic polymers or by physical/ mechanical means exemplified by electroporation. 9, 10 Effective use of these methods is limited by the low transfection efficiency, the transient expression of gene product and the lack of organ and tissue specificity. Previous studies have suggested that sonoporation (transient increase in cell membrane permeability by ultrasonic exposure) could be an alternative approach as it is not only rapid, reproducible and relatively inexpensive but also provides a safe, noninvasive and efficient means suitable for in vivo gene delivery. 11, 12 Ultrasonic exposure reversibly increases the cell membrane permeability by inducing transient acoustic cavitation to facilitate intracellular uptake of molecules. 13, 14 Moreover, ultrasound can be focused specifically on a location where the target gene is to be delivered. Microbubbles, as the ultrasonic contrast agent, improve the efficiency of ultrasound-mediated gene transfection by lowering the threshold for cavitation initiated by ultrasound energy, 15 inducing transient pores in the cell membrane 16 and releasing genetic material such as plasmid DNA that has been pre-incorporated into microbubbles locally. 17 Isolated reports have documented successful application of the ultrasound-microbubble-mediated system in transfecting naked-DNA in vivo in various types of murine tissues as well as in chicken embryos and murine fetuses. 16, [18] [19] [20] [21] [22] [23] Although the ultrasound-microbubblemediated gene delivery has been applied in carotid or kidney in murine models, 18, 19 isolation and temporary ligation of blood vessels or related organs during the transfection process are invasive and technically difficult to achieve for practical use in real life. Furthermore, intravenous injection leads not only to a dilution of genetic material in circulation but also to a retention of these substances in lung and liver. 24, 25 Despite recent advances in ultrasound-microbubble-mediated transfection, the intraperitoneal route of gene transfection remains unexplored.
In the present study, we investigated the efficiency of gene transfection into peritoneal tissues using the ultrasound-microbubble-mediated system. We explored the feasibility of gene delivery by intravenous and intraperitoneal route, evaluated the effect of ultrasound on transfection efficiency and determined the duration of gene expression in peritoneal tissues.
Results

Effect of ultrasound on gene transfection efficiency
The gene expression of Smad7 was markedly increased by 235% in the anterior abdominal wall and by 154% in the mesentery of rats receiving ultrasound as compared with those receiving no ultrasound (0.79070.225 vs 0.23670.019 in the anterior abdominal wall, P ¼ 0.047; 1.73170.434 vs 0.68270.277 in the mesentery, P ¼ 0.032) ( Figures 1A and B) . The protein synthesis of Smad7 was increased by 166% in the anterior abdominal wall and by 59% in the mesentery in rats receiving ultrasound as compared with those receiving no ultrasound (0.89470.073 vs 0.33670.037 in the anterior abdominal Figure 1 Effect of ultrasound on transfection efficiency in the peritoneum. Compared with gene delivery alone without ultrasound exposure (open columns), the gene expression of pTRE-Smad7 was upregulated in (A) the anterior abdominal wall and (B) mesentery of animals with ultrasound exposure (solid columns). The protein synthesis of pTRE-Smad7 was also enhanced in (C) the anterior abdominal wall and (D) mesentery exposed to ultrasound. (E) Representative immunostaining for flag-tagged exogenous Smad7 in the anterior abdominal wall of (a) rats receiving no transfection, (b) rats receiving plasmid/microbubbles without ultrasound exposure and (c) rats receiving plasmid/ microbubbles with ultrasound exposure. The exogenous Smad7 was mainly distributed in the mesothelial and the submesothelial compact zone of the parietal peritoneum (arrows). (magnification: Â 400; *Po0.05, **Pp0.001 vs no ultrasound). Figures 1C and D) . Immunohistochemical examination confirmed increased staining of flagged Smad7 in the rats exposed to ultrasound as compared with those receiving no ultrasound ( Figure  1E ). The exogenous Smad7 was mainly localized in the mesothelial and the submesothelial compact zone of the anterior abdominal wall. Hemorrhage, necrosis or increased accumulation of neutrophils and lymphocytes was not observed in parietal and visceral peritoneum ( Figure 2 ). There was increased number of apoptotic cells after ultrasound with Optison ( Figure 3 ). The apoptosis index was increased in both the anterior abdominal wall and mesentery of the ultrasound-microbubble treated animals compared with that of the untreated animals (abdominal wall: 6.271.85% vs 0.7670.30%; mesentery: 9.6472.17% vs 1.2470.68%; Po0.001).
Effect of the route of administration on gene delivery
The peritoneal gene expression of Smad7 was higher in rats receiving gene delivery via the intraperitoneal route than those via the intravenous route (Figure 4a) . Quantitation of the protein synthesis of Smad7 by antiflag m2 antibody also revealed that transfection via the intraperitoneal route exhibited higher transfection efficiency as compared to findings with the intravenous route (Figure 4b ).
Intra-abdominal organ distribution of Smad7
The gene expression of pTRE-Smad7 was detected in the anterior abdominal wall, adipose tissue, mesentery, greater omentum and spleen, but not in the liver, kidney, pancreas and intestine ( Figure 5 ).
Time course of transgene expression in peritoneal tissues
Following gene transfection, the gene expression and protein synthesis of pTRE-Smad7 diminished in both parietal and visceral peritoneum in a time-dependent manner. However, pTRE-Smad7 expression was still detected two weeks after initial gene transfection ( Figure 6 ).
Discussion
In this study, we have demonstrated that the ultrasoundmicrobubble-mediated system facilitates the transduction of naked plasmid DNA into the peritoneum in vivo. In the literature, most gene transfer methods for peritoneal membrane are adenovirus mediated. 26 However, the practical application of virus-mediated gene delivery in vivo is hampered by virus-induced acute inflammation, high immunogenicity, low tissue specificity and potential mutanogenesis. Among nonviral gene delivery methods, the ultrasound-microbubble-mediated system is a promising approach for in vivo gene transfer with minimal cytotoxicity and high transfection efficiency. 27 Naked plasmid DNA that can be produced in a large scale with better quality control than viral vectors, has shown its safety and low immunogenicity in extensive studies including clinical trials. 28 Increasing evidence has demonstrated that sonoporation is able to increase the transfection efficiency in various cell types and organs. 16, 19, 27, 29 Delivery of genetic material is greatly enhanced by ultrasound in the presence of microbubbles through which the energy of relatively noninteractive pressure waves is concentrated to produce forces that permeabilize cell membranes and disrupt the vesicles that carry the gene. 30 Upon ultrasound treatment, the microbubbles close to the cells not only exert a mechanical force on the membrane but also collapse. If the collapse is adjacent to a solid boundary like the cell membrane, a liquid jet at sonic speed will shoot directly into the cell. This causes sonoporation to allow materials such as DNA, exterior to the cell, to enter. 31, 32 In our study, a microbubble contrast agent containing albumin-stabilized perfluorocarbon gas filled microspheres (Optison) that has been established for safe clinical use was employed for efficient transfection. 15, 33 Microbubbles collapse by insonation and the gas bodies are removed from the circulation within about 5 min in mice and 15 min in humans. 34, 35 Similar to earlier observations that ultrasound increases transfection efficiency in a variety of tissues in vivo including brain, heart and muscle, 12, 36, 37 we observed increased expression of delivered gene in both parietal and visceral peritoneum following ultrasound exposure. In addition, compared with intraperitoneal gene transfection using polyethylenimine, only very low amount of transgene remained detectable after 72 h, 38 the transgene persists longer in our study signifying the high transfection efficiency by this ultrasound-microbubble-mediated system. We demonstrated for the first time that using ultrasound and microbubble as nonviral transfer agents is safe without eliciting either significant apoptosis by ultrasoundmicrobubble exposure or inflammatory reactions in the peritoneum that are associated with viral vectors. In in vivo gene delivery experiments under similar ultrasonic intensity, frequency and duration, the temperature rise was found to be less than 2 1C. 39 Interestingly, we also found that Optison alone could enhance gene delivery in peritoneal tissues at levels lower than ultrasoundmicrobubble-mediated delivery. These findings are in accord with the observation by Lu et al. 37 that microbubbles alone significantly increase the gene transfer in mouse skeletal muscle in vivo even in the absence of ultrasound, but contrast to the observation by Manome et al. 36 that no expression of delivered gene Figure 2 Hematoxylin-eosin staining of parietal and visceral peritoneum in rats. Hemorrhage, necrosis or increased accumulation of neutrophils and lymphocytes was not observed in the submesothelial layer of anterior abdominal wall and the interstitium of mesentery in rats receiving transfection.
Peritoneal gene transfer by ultrasound/microbubble H Guo et al is detected in mouse brain with microbubbles (Levovist) alone. This discrepancy may be due to the differences in the target tissue, microbubbles, animal species and size of plasmid DNA. It is speculative that the bursting microbubbles, in the absence of ultrasound, may generate sufficient force for inducing cavitation in the peritoneal membrane despite that the force is likely much smaller than that with ultrasound exposure. The ultrasonic exposure levels for gene transfer in our study (for example, intensity and frequency) are within normal therapeutic limits. 27, 33, 40 It should be recognized that ultrasound-microbubble-induced transient cavitation during gene transfection may inevitably lead to cellular injury or apoptosis via ischemia after cavitationproduced damage to exposed cells. 30 Some collateral lesions exhibit red blood cell extravasations and even rupture of microvessels in the exposed area. 34, 41 In vivo studies of ultrasound-microbubble-mediated transfection have shown apoptosis in 17% of exposed cells in the rabbit brain 42 and less than 1% of all treated skeletal muscle of rats. 43 Amabile et al. 44 reported apoptosis in 26% of vascular endothelial cells following endovascular ultrasound delivery of adenovirus-expressing gene. In our study, the apoptosis index increased slightly in both the anterior peritoneal wall and mesentery of the ultrasound-treated animals. This is not beyond our expectation due to transient permeabilization of the cell membrane induced by acoustic cavitation. Under our present protocol, we are able to maintain the apoptosis index to less than 10%. Lowering of sonoporation intensity could further reduce the apoptosis index but will also compromise the transfection efficiency. Any change of ultrasound parameters, including the acoustic frequency, intensity, duty cycle and exposure duration, would affect the transfection rate and concomitant tissue damage. We therefore stress that for in vivo application of sonoporation, a balance should be adjusted to maximize the transfection efficiency and to minimize the cell damage.
While previous experiments of ultrasound-microbubble-mediated transfection were conducted by direct ultrasonic application over the organ following intraarterial injection of plasmid/microbubbles, we achieved a peritoneum-preferential transgene expression with transcutaneous application of ultrasound over the abdominal wall. The spatial control of desired effects to the targeted tissues and organs is another important factor to be considered for gene delivery. In order to obtain sufficient and effective exposure of the targeted tissues (mesothelial and submesothelial layer of the peritoneum) to the ultrasound, the transducer was placed perpendicularly over the abdominal wall and scanned over the entire abdominal wall. This enables gene transfection throughout the anterior part of the peritoneum. The transgene was distributed among the parietal (mesothelium and submesothelial compact zone) and visceral peritoneum (mesentery and greater omentum), the adipose tissue and, with a little retention in the spleen. Peritoneal mesothelial cells constitute the primary target cell population for genetic modification. Nevertheless, a limitation for the present technique is the lack of selection for depth of treatment and further investigation need to improve better spatial control of gene delivery. Previous study has shown that plasmid DNA can be transfected into peritoneal mesothelial cells by electroporation in vitro. 45 It is likely that when the ultrasound beam passes through the anterior abdominal wall, the ultrasound and microbubbles cause cavitation near the membrane surface of mesothelial cells and other Peritoneal gene transfer by ultrasound/microbubble H Guo et al resident cells in the submesothelial layer, including macrophages, lymphocytes, neutrophils, fibroblasts and endothelial cells, finally leading to an increase of DNA uptake in the submesothelial compact zone. Interestingly, other intra-abdominal organs such as the liver, kidney, pancreas and intestine showed no transgene expression. It is conceivable that the peritoneal lining not only captures the plasmid DNA but also acts as a barrier preventing the spread of transgene into the underlying organ parenchyma. 38, 46 Hence, the ratio of untransfected cells in these organs to the transfected cells in the peritoneal lining may be too large to detect the effective transfection in these organs.
A successful transfection method must be a means by which the expression of the transgene can be controlled. We also noted that the delivered transgene expressed in the peritoneum decreased in a time-dependent manner, which is similar to that in other tissues. 12, 21, 27 Hence, the duration of transgene expression can be regulated by repeated administration via the peritoneal route. We used Smad7, an inhibitor of TGF-b/Smad signaling pathway, as a prototype for our transfection experiment. Arguably, effective transfection of Smad7 in the peritoneal cavity using ultrasound and microbubbles may provide a potential therapeutic intervention in the progression of peritoneal fibrosis complicating surgery or long-term peritoneal dialysis.
We found that the intraperitoneal route of gene transfer achieves higher transfection efficiency in peritoneal tissues than the intravenous route. Although the elastic and compressible features render microbubbles firm enough to resist the blood pressure and the diameter of around 3 mm which enables microbubbles to pass through the pulmonary circulation, 19 it is conceivable that the intravenously injected plasmid/microbubbles are rapidly degraded and cleared by serum esterases or proteinase in blood circulation. 47 The endothelial barrier may be another factor causing the loss of genetic materials when the macromolecules pass across the capillary fenestrations of blood vessels. 17 In contrast, plasmid/microbubbles may directly distribute in the peritoneal cavity through intraperitoneal injection without any loss. Hence, gene transfer occurs at the peritoneal surface immediately following the exposure to ultrasound. Other investigators had observed no toxicity or peritoneal dysfunction with intraperitoneal administration of cationic polymers-DNA, even with amount several folds higher than the intravenous lethal dose. 25, 38 Therefore, our findings reveal that the intraperitoneal gene delivery into peritoneal tissues is superior to intravenous route with respect to transfection efficiency and safety.
There are, indeed, limitations in this study. The use of the doxycycline-driven promoter is helpful in controlling the gene expression and doxycycline per se does not interfere with the native proteins in the body. Yet we could not exclude the possibility of doxycycline-induced cytotoxicity or other side effects, albeit not common. 48 Although the intraperitoneal transfection mediated by ultrasound and microbubbles is peritoneal preferential that is suitable for peritoneal diseases, the lack of spatial control of the technique has to be improved. Activation of heat-inducible promoter such as heat shock protein-70B (hsp70B) has been achieved by focused ultrasound and may be an attractive alternative to our ultrasoundmicrobubble-induced gene transfer system. 49, 50 In summary, the ultrasound-microbubble-mediated system is a convenient and efficient method for gene transfection in the peritoneal tissue in vivo, though more specific spatial control should be improved. This system provides a novel therapeutic approach of delivering a timed 'gene therapy' to peritoneal tissues for peritoneal injury.
Materials and methods
Plasmid DNA
Mouse Smad7 cDNA with a flag tag (m2) at its NH2 terminus in pcDNA3 (gift from Dr H Zhu, Ludwig Institute for Cancer Research, Victoria, Australia) was subcloned into a tetracycline-inducible vector, pTRE (Clontech, Palo Alto, CA, USA), to obtain pTREm2Smad7 (4.5 kb). To achieve doxycycline (a tetracycline derivative)-induced Smad7 transgene expression, pTREm2Smad7 and an improved pTet-on vector (Clontech), pEFpurop-Tet-on (7.2 kb, gift from Dr G Vario, Cerylid, Melbourne, Australia), were cotransfected into the peritoneal cavity using ultrasound delivery. The plasmid DNA obtained from Escherichia coli DH5a culture was purified with the Qiagen Plasmid Maxi kit (Qiagen Inc., Valencia, CA, USA) according to the manufacturer's instruction. The identity and purity of the plasmid DNA were confirmed by 1% agarose gel electrophoresis before and after restriction endonucleases digestion.
Preparation of naked plasmid DNA-microbubble mixture
Plasmid DNA including equal quantity of pTREm2Smad7 and pEFpurop-Tet-on was dissolved in 0.9% of saline. Albumin-stabilized perfluorocarbon gas microbubbles (Optison, Amersham Health Inc., Princeton, NJ, USA) were gently resuspended before each aliquot was withdrawn. Prepared plasmids and the Optison were mixed in 1:1 v/v ratio.
In vivo gene transfer into peritoneal cavity in rats
Healthy male Sprague Dawley rats weighing from 200 to 250 g were used in the study. All animal procedures were performed under the standard condition in the Laboratory Animal Unit of the University of Hong Kong. All experiments conformed to approve animal care protocols of the institution.
Rats were anesthetized by isoflurane inhalation (Halocarbon Laboratories, North Augusta, SC, USA). The mixture of naked plasmid DNA and Optison was injected intraperitoneally at the right lower quadrant using an 18G needle. They were massaged gently for better distribution of plasmid/microbubbles in the peritoneal cavity. Then the shaved surface of the anterior abdominal wall was covered with acoustically transparent ultrasound gel (Aquasonic Clear, Parker Laboratories Inc., Fairfield, NJ, USA) and exposed to the ultrasound transducer (Sonitron, 2000, Rich-Mar Corp., Inola, OK, USA). As the peritoneum was the target tissue, rats were first face-laid so that enough microbubbles covered the parietal peritoneum in order to absorb the ultrasound energy. Then rats were back-laid to facilitate ultrasound and microbubbles reaching the visceral peritoneum. The transducer, with a diameter of 2 cm, covered an area of 3.14 cm 2 at each region of anterior abdominal wall. Optimal dose and routes of gene transfection into peritoneal cavity In our pilot study, different doses of plasmid (25 mg, 50 mg and 100 mg) were transfected into the abdomen either by intraperitoneal or by intravenous route of delivery. The expression of delivered gene was detected in rats receiving 100 mg of Smad7 transgene, but not in those receiving 25 mg and 50 mg of plasmid. In subsequent sets of experiments, 100 mg of plasmid was used for the gene transfer. The gene delivery via the intraperitoneal route was performed as mentioned above. For gene transfer through the intravenous route, an access in the tail vein using a 21-gauge angiocatheter with a 3-way stopcock was inserted before the injection. The ultrasonic condition was stated as above. Previous work in kidney had demonstrated that the peak expression of intra-arterially delivered plasmid occurs at 48 h. 27 In our study, rats were killed 2 days following the gene delivery and the tissues were collected.
Effect of ultrasound on gene transfection
Following intraperitoneal injection of plasmid DNA mixed with equal volume of Optison, one group of rats was exposed to ultrasound while another group received no ultrasonic exposure as control. Doxycycline was administered to both groups as mentioned above. Rats were killed 2 days after the gene delivery and the tissues were collected for the assessment of transgene expression, immune response and apoptosis.
Time-dependent manner of transfection
A mixture of plasmid DNA and equal volume of Optison was injected intraperitoneally followed by application of the ultrasound. Doxycycline was administered as mentioned above. The rats were killed on day 2, day 4 and day 14 after transfection.
Tissue collection
Peritoneal tissues including randomly selected regions of anterior abdominal wall, adipose tissue, mesentery and greater omentum were collected from identical sites in all the rats after they were killed. Other abdominal organs including liver, kidney, spleen, pancreas and intestine were also collected. Part of the tissues were fixed in 10% neutral buffered formalin for immunohistochemistry and the remaining were kept at À70 1C for total RNA and protein extraction.
Histology and immunohistochemistry
Sections (5-mm thick) of the anterior abdominal wall were stained with hematoxylin and eosin and examined for the alterations of peritoneal structure and the accumulation of inflammatory cells in the peritoneum.
Immunohistochemical analysis was performed in the anterior abdominal wall using paraffin-embedded sections by indirect method. In brief, after deparaffinization and rehydration, all sections were incubated with 0.3% H 2 O 2 solution for blockade of endogenous peroxidase activity. The sections were then blocked with 5% bovine serum albumin (BSA) in Tris-buffered saline buffer (TBS), pH 7.4, followed by incubation with primary antibody mouse anti-flag m2 (Sigma) overnight at room temperature. The bound antibodies were detected using the Dako Envision Plus kits (Dako, Carpinteria, CA, USA).
RNA isolation and RT-PCR
Total RNA was extracted from tissues using the guanidinium thiocyanate-phenol-chloroform method with ToTALLY RNA Kit (Ambion, Austin, TX, USA). The purity of RNA was monitored by the optical density 260/280 ratio. After total RNA was reversely transcripted to cDNA, PCR was carried out. For quantification, primers for glyceraldehydes-3-phosphate-dehydrogenase (GAPDH) were determined as an internal control. The sequences of primer were as follows: pTRE-Smad7, forward primer 5 0 -TTT ACA ACC GCA GCA GTT ACC and reveres primer 5 0 -CAT AAT CAG CCA TAC CAC ATT; GAPDH, forward primer 5 0 -ACC CCT TCA TTG ACC TCA ACT and reverse primer 5 0 -ACC AGG AAA TGA GCT TCA CAA A. PCR was carried out with 30-38 cycles of amplification at an annealing temperature of 56-62 1C. The PCR products were separated by 2% wt vol À1 agarose gels and stained with ethidium bromide. The gel image was captured and analyzed using the Gel Doc 1000 Densitometry System and Quantity One (Bio-Rad, Hercules, CA, USA). The PCR product yielded was expressed as a ratio to the GAPDH amplicon.
Western blot for flag m2 protein in abdomen
Rat peritoneal tissues and other tissues including kidney, liver, pancreas, spleen and small intestine were grounded and homogenized in a lysis buffer containing 10 mM Tris, 150 mM NaCl, 5 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 1% Triton X-100 and complete protease inhibitors. From each lysate, 40mg of protein were dissolved in a loading buffer containing 62.5 mM Tris-HCl, pH 6.8, 2% sodium dodecyl sulfate (SDS), 10% glycerol, 0.01% bromophenol blue and 5% b-mercaptoethanol before boiling for 5 min. Each sample was electrophoresed on 12% SDS polyacrylamide gel. Proteins were then transferred to nitrocellulose membranes using a mini blot apparatus (Bio-Rad). Membranes were blocked with 5% BSA in TBS-T (0.1% Tween-20 in Trisbuffered saline buffer) for 1 h at room temperature with constant shaking before washing three times with TBS-T. The membranes were then incubated with mouse antiflag m2 (Sigma) with a dilution of 1:4000 in TBS-T with constant shaking overnight at room temperature. After washing three times with TBS-T, membranes were incubated with a 1:30 000 dilution of horseradish peroxide-conjugated goat anti-mouse antibodies (Dako Peritoneal gene transfer by ultrasound/microbubble H Guo et al A/S, Copenhagen, Denmark) at room temperature for 1 h. The membrane was extensively washed with TBS-T and the bound antibodies were detected with ECL plus chemiluminescence (Amersham Pharmacia Biotech, Arlington, IL, USA). Densitometry result was reported as a ratio to the actin signal.
In situ detection of apoptosis
The level of apoptosis was determined by a TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) assay carried out with the ApopTaq Fluorescein In Situ Apoptosis Detection Kit (Chemicon International, Temecula, CA, USA) following the manufacturer's protocol. Cells were regarded as TUNELpositive if they exhibited stained nuclei (green color) with apoptotic morphology. Apoptosis was quantified in a blinded manner by counting the number of TUNELpositive cells in 10 sequentially selected nonoverlapping fields of abdominal wall and mesentery at a magnification of Â 400. The total number of cells was also determined by nuclear counter-stained with DAPI (6-diamidino-2-phenylindole diacetate, blue color). At least four different sections per animal were evaluated. Data were expressed as the apoptosis index calculated as the percentage of TUNEL positive cells per total number of cells evaluated.
Statistical analysis
The results are expressed as mean7s.d. Differences in parameters between groups were evaluated by twotailed Student's t-test. A 'P' value o0.05 was considered significant. All analyses were performed with a SPSS 12.0 statistical package.
